Business
OncoSec Medical to Present at Two Events in February
OncoSec Medical to Present at Two Events in February.
About this update from Oncosec Medical Incorporated
[{"type":"text","content":"\n \n OncoSec Medical Inc. (OTCQB: ONCS), \n a company developing DNA-based intratumoral cancer immunotherapies, \n announced today that it will present at two high-profile scientific and \n investment conferences in February.\n \n \n BIO CEO & Investor Conference\n \n \n Punit Dhillon, President and CEO, will present a corporate overview at \n the 17th Annual BIO CEO & Investor Conference, on February 9-10, 2015 in \n New York City, NY. The presentation is scheduled to begin at 9:30 AM ET \n on Monday, February 9 in the Duke of Windsor room.\n \n \n At the time of the presentation, a live webcast will be available via \n the following link: http://www.veracast.com/webcasts/bio/ceoinvestor2015/43106259832.cfm\n \n \n OncoSec recommends registering at least 10 minutes prior to the start of \n the presentation to ensure timely access. After the presentation, an \n archived version of the webcast will be available for 90 days in the \n “Events” section of the OncoSec web page at http://www.oncosec.com.\n \n \n Each year, the BIO CEO & Investor Conference provides a forum for \n institutional investors, industry analysts, and senior biotechnology \n executives to shape the future investment landscape of the biotechnology \n industry. The conference features issue-oriented plenary sessions, \n educational sessions focused on hot therapeutic areas and key business \n issues, company presentations, one-on-one meetings, and networking \n opportunities. For more information, visit: https://www.bio.org/events/conferences/bio-ceo-investor-conference\n \n \n Molecular Medicine Tri-Conference 2015\n \n \n Robert H. Pierce, MD, Chief Scientific Officer, will present at \n Cambridge Healthtech Institute’s 22nd International Molecular Medicine \n Tri-Conference, on February 15-20, 2015 at Moscone North Convention \n Center in San Francisco, CA. Dr. Pierce’s lecture, “Translational \n Approaches for the Development of Intratumoral Immunotherapies,” is \n scheduled to begin at 11:15 AM PT on Tuesday, February 17.\n \n \n The 22nd International Molecular Medicine Tri-Conference is the \n industry's preeminent event on molecular medicine, focusing on drug \n discovery, genomics, diagnostics and information technology. Spanning \n six days this year, the Tri-Conference includes an expanded program that...